Cell type markers indicate distinct contributions of decidual stromal cells and natural killer cells in preeclampsia.


Journal

Reproduction (Cambridge, England)
ISSN: 1741-7899
Titre abrégé: Reproduction
Pays: England
ID NLM: 100966036

Informations de publication

Date de publication:
01 11 2022
Historique:
received: 04 03 2022
accepted: 15 09 2022
pubmed: 17 9 2022
medline: 20 10 2022
entrez: 16 9 2022
Statut: epublish

Résumé

Preeclampsia is a common serious disorder that can occur during pregnancy. This study uses integrative analysis of preeclampsia transcriptomes and single-cell transcriptomes to predict cell type-specific contributions to preeclampsia. Preeclampsia is a devastating pregnancy disorder and a major cause of maternal and perinatal mortality. By combining previous transcriptomic results on preeclampsia with single-cell sequencing data, we here predict distinct and partly unanticipated contributions of decidual stromal cells and uterine natural killer cells in early- and late-onset preeclampsia.

Identifiants

pubmed: 36111648
doi: 10.1530/REP-22-0079
pii: REP-22-0079
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

V9-V13

Auteurs

Kalle T Rytkönen (KT)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, Finland.

Nigatu Adossa (N)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.

Mehrad Mahmoudian (M)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, Finland.

Tapio Lönnberg (T)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
InFLAMES Research Flagship Center, University of Turku, Turku, Finland.

Matti Poutanen (M)

Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, Finland.

Laura L Elo (LL)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
Institute of Biomedicine, University of Turku, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH